To address this issue, Edwards Lifesciences convened a roundtable, including representatives from the medical device, diagnostic, and pharmaceutical industries, private hospital operators, clinicians and clinical societies, patient advocates, and other subject matter experts.
Unlocking Better Cancer Outcomes with Rapid Genomic Testing
Learn how rapid Next Generation Sequencing (NGS) is unlocking a new era of precision cancer care in Australia, with faster diagnosis, more personalised treatment, and system-wide benefits.
Environmental Sustainability and Healthcare Access – Shaping the Future
The healthcare sector faces a critical challenge balancing the imperative to provide high-quality patient care with the urgent need to address its significan environmental impact.
Genetic Sequencing for Children
One in 17 people will encounter a rare disease of genetic origin in their lifetime. Approximately half of those will be children, with 30% of those children not surviving beyond the age of 5 years.
The impact of a new model of care for cardiovascular disease in Australia
Cardiovascular disease (CVD) is a significant public health concern in Australia, with potentially devastating effects on individuals and a substantial burden on the healthcare system.
Impact assessment and the NDIS
Globally over 1 billion people, or approximately 15% of the world’s population, are estimated to experience disability. Efforts must continue to drive and promote the inclusion, engagement and full participation of people with disability in all aspects of our society.
Discussing the impact of disability
Globally over 1 billion people, or approximately 15% of the world’s population, are estimated to experience disability. Efforts must continue to drive and promote the inclusion, engagement and full participation of people with disability in all aspects of our society.